These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 19747165)

  • 21. Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells.
    Kim SH; Juhnn YS; Song YS
    Ann N Y Acad Sci; 2007 Jan; 1095():82-9. PubMed ID: 17404021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
    Page C; Lin HJ; Jin Y; Castle VP; Nunez G; Huang M; Lin J
    Anticancer Res; 2000; 20(1A):407-16. PubMed ID: 10769688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells.
    Isonishi S; Saitou M; Saitou M; Yasuda M; Tanaka T
    Oncol Rep; 2007 Jul; 18(1):195-201. PubMed ID: 17549368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
    Chan DW; Liu VW; Tsao GS; Yao KM; Furukawa T; Chan KK; Ngan HY
    Carcinogenesis; 2008 Sep; 29(9):1742-50. PubMed ID: 18632752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway.
    Yang YI; Lee KT; Park HJ; Kim TJ; Choi YS; Shih IeM; Choi JH
    Carcinogenesis; 2012 Dec; 33(12):2488-98. PubMed ID: 23027625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cells.
    Du F; Wu X; Liu Y; Wang T; Qi X; Mao Y; Jiang L; Zhu Y; Chen Y; Zhu R; Han X; Jin J; Ma X; Hua D
    Oncol Rep; 2013 Sep; 30(3):1113-8. PubMed ID: 23807572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: more than just AKT inhibition.
    Sun H; Yu T; Li J
    Cancer Lett; 2011 Nov; 310(1):118-28. PubMed ID: 21775054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of the integrin-linked kinase gene induces the apoptosis in ovarian carcinoma.
    Liu Q; Xiao L; Yuan D; Shi X; Li P
    J Recept Signal Transduct Res; 2012 Apr; 32(2):120-7. PubMed ID: 22384810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance.
    Loessner D; Quent VM; Kraemer J; Weber EC; Hutmacher DW; Magdolen V; Clements JA
    Gynecol Oncol; 2012 Dec; 127(3):569-78. PubMed ID: 22964375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.
    Sato S; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Iba T; Naniwa J; Uegaki K; Terakawa N
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):247-52. PubMed ID: 14610615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells.
    Aoudjit F; Vuori K
    Oncogene; 2001 Aug; 20(36):4995-5004. PubMed ID: 11526484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells.
    Uehara N; Matsuoka Y; Tsubura A
    Mol Cancer Res; 2008 Feb; 6(2):186-93. PubMed ID: 18245228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
    Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
    Le XF; Mao W; He G; Claret FX; Xia W; Ahmed AA; Hung MC; Siddik ZH; Bast RC
    J Natl Cancer Inst; 2011 Sep; 103(18):1403-22. PubMed ID: 21813412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly.
    Hu Q; Li W; Hu X; Hu Q; Shen J; Jin X; Zhou J; Tang G; Chu PK
    Biomaterials; 2012 Sep; 33(27):6580-91. PubMed ID: 22717365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.
    Inami K; Kajino K; Abe M; Hagiwara Y; Maeda M; Suyama M; Watanabe S; Hino O
    Oncol Rep; 2008 Dec; 20(6):1375-80. PubMed ID: 19020717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference with ATF5 function enhances the sensitivity of human pancreatic cancer cells to paclitaxel-induced apoptosis.
    Hu M; Wang B; Qian D; Li L; Zhang L; Song X; Liu DX
    Anticancer Res; 2012 Oct; 32(10):4385-94. PubMed ID: 23060563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel.
    Rong F; Li W; Chen K; Li DM; Duan WM; Feng YZ; Li F; Zhou XW; Fan SJ; Liu Y; Tao M
    Neoplasma; 2012; 59(5):541-50. PubMed ID: 22668020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.